Critical Care Outcomes of Hematologic Oncology Patients

Active, not recruitingOBSERVATIONAL
Enrollment

415

Participants

Timeline

Start Date

February 26, 2018

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Hematologic MalignancyStem Cell Transplant
Trial Locations (13)

T2N 2T9

Foothills Hospital, Calgary

T6G 2R3

University of Alberta, Edmonton

V5Z 1M9

Vancouver General Hospital, Vancouver

R3T 2N2

University of Manitoba, Winnipeg

B3H 2Y9

Queen Elizabeth II Health Sciences Centre, Halifax

L8V 1C3

Juravinski Hospital, Hamilton

K7L 2V7

Kingston General Hospital, Kingston

K1H 8L6

Ottawa Hospital, Ottawa

M4N 3M5

Sunnybrook Health Sciences Centre, Toronto

M5G 1X5

Mount Sinai Hospital, Toronto

M5G 2M9

University Health Network, Toronto

H1T 2M4

Maisonneuve-Rosemont Hospital, Montreal

H4A 3J1

Royal Victoria Hospital, Montreal

All Listed Sponsors
lead

Mount Sinai Hospital, Canada

OTHER

NCT03449953 - Critical Care Outcomes of Hematologic Oncology Patients | Biotech Hunter | Biotech Hunter